Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TheaLoz Duo Eyedrop for Dry Eye in Gamers
NCT06163989Recruiting
- Sponsor
- Aston University
- Start
- Sep 2024
- Primary completion
- Dec 2026
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of sodium hyaluronate + trehalose in dry eye syndrome (DED) and computer vision syndrome (CVS) (2 arms), sponsored by Aston University. Primary endpoint: Ocular Surface Disease Index at 2 months. Started Sep 2024; status: recruiting.
02
Drugs
sodium hyaluronate + trehalose
03
Conditions
dry eye syndrome (DED)computer vision syndrome (CVS)
Beyond the preview
Go deeper on NCT06163989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06163989.